World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
42374
World Ranking
6008
National Ranking
3214

Overview

Bianca Weinstock-Guttman is affiliated with the University at Buffalo, State University of New York in the United States. Their research primarily focuses on medicine, with a significant concentration in pathology and forensic medicine, neurology, rheumatology, radiology, nuclear medicine and imaging, and molecular biology.

Their work extensively covers multiple sclerosis research studies, peripheral neuropathies and disorders, advanced neuroimaging techniques and applications, polyomavirus-related diseases, systemic lupus erythematosus research, rheumatoid arthritis research and therapies, and the long-term effects of COVID-19.

Some of their recent publications include:

  • Multiple sclerosis (2023), The Lancet
  • Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis (2020), Annals of Neurology
  • Improved relapse recovery in paediatric compared to adult multiple sclerosis (2020), Brain
  • Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment (2021), CNS Drugs
  • Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis (2022), Neurology

Weinstock-Guttman frequently collaborates with several researchers, including Robert Zivadinov, Dejan Jakimovski, Michael G. Dwyer, Niels Bergsland, and Ralph H. B. Benedict. These collaborations reflect a network focused on neurological research and multiple sclerosis studies.

Their work has been published in several venues, with notable frequent contributions to Neurology, Multiple Sclerosis and Related Disorders, Multiple Sclerosis Journal, Journal of Neurology, and Annals of Clinical and Translational Neurology.

Best Publications

  • Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis

    Lawrence D. Jacobs;Diane L. Cookfair;Richard A. Rudick;Robert M. Herndon

  • Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

    Richard A. Rudick;William H. Stuart;Peter A. Calabresi;Christian Confavreux

  • Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)

    Ralph H.B. Benedict;Diane Cookfair;Rebecca Gavett;Mark Gunther

  • Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

    Ralph H.B. Benedict;Elizabeth Wahlig;Rohit Bakshi;Inna Fishman

  • Thalamic atrophy and cognition in multiple sclerosis

    M. K. Houtchens;R.H.B. Benedict;R. Killiany;J. Sharma

  • Prediction of Neuropsychological Impairment in Multiple Sclerosis Comparison of Conventional Magnetic Resonance Imaging Measures of Atrophy and Lesion Burden

    Ralph H. B. Benedict;Bianca Weinstock-Guttman;Inna Fishman;Jitendra Sharma

  • Eight-year follow-up study of brain atrophy in patients with MS

    E. Fisher;R. A. Rudick;J. H. Simon;G. Cutter

  • Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis

    Jack H. Simon;Lawrence D. Jacobs;Marilyn Campion;Karl Wende

  • Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

    Brenda Banwell;Lauren Krupp;Julia Kennedy;Raymond Tellier

  • Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis

    Ralph H. B. Benedict;Jared M. Bruce;Michael G. Dwyer;Nadir Abdelrahman

  • Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

    R H B Benedict;I Fishman;M M McClellan;R Bakshi

  • The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL

    P. A. Calabresi;G. Giovannoni;C. Confavreux;S. L. Galetta

  • Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

    Sonia Batista;Robert Zivadinov;Marietta Hoogs;Niels Bergsland

  • Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test

    B A Parmenter;B Weinstock-Guttman;N Garg;F Munschauer

  • Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

    Michael P. Sanfilipo;Ralph H.B. Benedict;Bianca Weinstock-Guttman;Rohit Bakshi

  • Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

    Richard A. Rudick;N. A. Simonian;J. A. Alam;M. Campion

  • Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

    B. A.C. Cree;O. Khan;D. Bourdette;D. S. Goodin

  • Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test

    A S Drake;B Weinstock-Guttman;S A Morrow;D Hojnacki

  • Reliable screening for neuropsychological impairment in multiple sclerosis.

    Ralph H. B. Benedict;Darcy Cox;Laetitia L. Thompson;Fred Foley

  • The interferons: biological effects, mechanisms of action, and use in multiple sclerosis.

    Weinstock-Guttman B;Ransohoff Rm;Kinkel Rp;Rudick Ra

Frequent Co-Authors

Robert Zivadinov
Robert Zivadinov University at Buffalo, State University of New York
Michael G. Dwyer
Michael G. Dwyer University at Buffalo, State University of New York
Niels Bergsland
Niels Bergsland University at Buffalo, State University of New York
Ralph H.B. Benedict
Ralph H.B. Benedict University at Buffalo, State University of New York
Tanuja Chitnis
Tanuja Chitnis Harvard University
Moses Rodriguez
Moses Rodriguez Mayo Clinic
Emmanuelle Waubant
Emmanuelle Waubant University of California, San Francisco
Lauren B. Krupp
Lauren B. Krupp New York University
Richard A. Rudick
Richard A. Rudick Biogen (United States)
Eva Havrdova
Eva Havrdova Charles University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative routes or stepping stones in healthcare? Today, many students explore online programs for greater flexibility and accessibility. For registered nurses aiming to advance, the cheapest bsn programs provide an affordable path to a Bachelor of Science in Nursing, often boosting career potential.

Those without a nursing background but eager to enter the field quickly might consider msn direct entry programs online. These intensive programs can lead to a Master of Science in Nursing—even for non-nurses—helping you fast-track into advanced practice roles.

If you’re searching for more accessible academic entry points, easiest rn program options may be ideal. These programs offer streamlined admission requirements, letting you begin your nursing journey sooner.

Not sure about clinical roles? There are broader healthcare careers available too. Check out online medical billing and coding schools that accept fafsa for reputable and financially-supported pathways into health administration and billing.

Best Scientists Citing Bianca Weinstock-Guttman

Trending Scientists

Recently Published Articles